Compare Stocks

2 / 10
Try these comparisons:

Stock Comparison

PRVA vs UNH

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
PRVA
Privia Health Group, Inc.

Medical - Healthcare Information Services

HealthcareNASDAQ • US
Market Cap$3.01B
5Y Perf.-33.9%
UNH
UnitedHealth Group Incorporated

Medical - Healthcare Plans

HealthcareNYSE • US
Market Cap$333.37B
5Y Perf.-7.9%

PRVA vs UNH — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
PRVA logoPRVA
UNH logoUNH
IndustryMedical - Healthcare Information ServicesMedical - Healthcare Plans
Market Cap$3.01B$333.37B
Revenue (TTM)$2.12B$449.71B
Net Income (TTM)$23M$12.04B
Gross Margin9.6%18.8%
Operating Margin1.6%4.2%
Forward P/E68.5x20.1x
Total Debt$10M$78.39B
Cash & Equiv.$480M$24.36B

PRVA vs UNHLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

PRVA
UNH
StockApr 21May 26Return
Privia Health Group… (PRVA)10066.1-33.9%
UnitedHealth Group … (UNH)10092.1-7.9%

Price return only. Dividends and distributions are not included.

Quick Verdict: PRVA vs UNH

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: UNH leads in 5 of 7 categories, making it the strongest pick for valuation and capital efficiency and profitability and margin quality. Privia Health Group, Inc. is the stronger pick specifically for growth and revenue expansion and recent price momentum and sentiment. As sector peers, any of these can serve as alternatives in the same allocation.
PRVA
Privia Health Group, Inc.
The Growth Play

PRVA is the clearest fit if your priority is growth exposure and sleep-well-at-night.

  • Rev growth 22.3%, EPS growth 63.6%, 3Y rev CAGR 16.1%
  • Lower volatility, beta 1.03, Low D/E 1.2%, current ratio 1.60x
  • 22.3% revenue growth vs UNH's 11.8%
Best for: growth exposure and sleep-well-at-night
UNH
UnitedHealth Group Incorporated
The Insurance Pick

UNH carries the broadest edge in this set and is the clearest fit for income & stability and long-term compounding.

  • Dividend streak 25 yrs, beta 0.59, yield 2.4%
  • 220.3% 10Y total return vs PRVA's 4.3%
  • Beta 0.59, yield 2.4%, current ratio 0.79x
Best for: income & stability and long-term compounding
See the full category breakdown
CategoryWinnerWhy
GrowthPRVA logoPRVA22.3% revenue growth vs UNH's 11.8%
ValueUNH logoUNHLower P/E (20.1x vs 68.5x)
Quality / MarginsUNH logoUNH2.7% margin vs PRVA's 1.1%
Stability / SafetyUNH logoUNHBeta 0.59 vs PRVA's 1.03
DividendsUNH logoUNH2.4% yield; 25-year raise streak; the other pay no meaningful dividend
Momentum (1Y)PRVA logoPRVA+5.6% vs UNH's -4.7%
Efficiency (ROA)UNH logoUNH3.9% ROA vs PRVA's 1.8%, ROIC 9.2% vs 9.9%

PRVA vs UNH — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

PRVAPrivia Health Group, Inc.
FY 2025
FFS-Patient Care
64.1%$1.4B
Capitated Revenue
14.5%$308M
Shared Savings
11.1%$235M
FFS-Administrative Services
6.5%$137M
Care Management Fee (PMPM)
3.4%$73M
Other Revenue
0.4%$9M
UNHUnitedHealth Group Incorporated
FY 2025
Unitedhealthcare
94.4%$332.4B
Optumhealth
5.6%$19.8B

PRVA vs UNH — Financial Metrics

Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLUNHLAGGINGPRVA

Income & Cash Flow (Last 12 Months)

Evenly matched — PRVA and UNH each lead in 3 of 6 comparable metrics.

UNH is the larger business by revenue, generating $449.7B annually — 211.8x PRVA's $2.1B. Profitability is closely matched — net margins range from 2.7% (UNH) to 1.1% (PRVA). On growth, PRVA holds the edge at +17.4% YoY revenue growth, suggesting stronger near-term business momentum.

MetricPRVA logoPRVAPrivia Health Gro…UNH logoUNHUnitedHealth Grou…
RevenueTrailing 12 months$2.1B$449.7B
EBITDAEarnings before interest/tax$44M$23.2B
Net IncomeAfter-tax profit$23M$12.0B
Free Cash FlowCash after capex$162M$19.7B
Gross MarginGross profit ÷ Revenue+9.6%+18.8%
Operating MarginEBIT ÷ Revenue+1.6%+4.2%
Net MarginNet income ÷ Revenue+1.1%+2.7%
FCF MarginFCF ÷ Revenue+7.6%+4.4%
Rev. Growth (YoY)Latest quarter vs prior year+17.4%+2.0%
EPS Growth (YoY)Latest quarter vs prior year+101.7%+0.7%
Evenly matched — PRVA and UNH each lead in 3 of 6 comparable metrics.

Valuation Metrics

UNH leads this category, winning 5 of 6 comparable metrics.

At 27.8x trailing earnings, UNH trades at a 79% valuation discount to PRVA's 133.3x P/E. On an enterprise value basis, UNH's 16.6x EV/EBITDA is more attractive than PRVA's 57.6x.

MetricPRVA logoPRVAPrivia Health Gro…UNH logoUNHUnitedHealth Grou…
Market CapShares × price$3.0B$333.4B
Enterprise ValueMkt cap + debt − cash$2.5B$387.4B
Trailing P/EPrice ÷ TTM EPS133.28x27.76x
Forward P/EPrice ÷ next-FY EPS est.68.48x20.06x
PEG RatioP/E ÷ EPS growth rate
EV / EBITDAEnterprise value multiple57.62x16.61x
Price / SalesMarket cap ÷ Revenue1.42x0.74x
Price / BookPrice ÷ Book value/share3.91x3.29x
Price / FCFMarket cap ÷ FCF18.58x20.74x
UNH leads this category, winning 5 of 6 comparable metrics.

Profitability & Efficiency

Evenly matched — PRVA and UNH each lead in 4 of 8 comparable metrics.

UNH delivers a 11.5% return on equity — every $100 of shareholder capital generates $12 in annual profit, vs $3 for PRVA. PRVA carries lower financial leverage with a 0.01x debt-to-equity ratio, signaling a more conservative balance sheet compared to UNH's 0.77x. On the Piotroski fundamental quality scale (0–9), UNH scores 6/9 vs PRVA's 5/9, reflecting solid financial health.

MetricPRVA logoPRVAPrivia Health Gro…UNH logoUNHUnitedHealth Grou…
ROE (TTM)Return on equity+3.1%+11.5%
ROA (TTM)Return on assets+1.8%+3.9%
ROICReturn on invested capital+9.9%+9.2%
ROCEReturn on capital employed+4.6%+9.7%
Piotroski ScoreFundamental quality 0–956
Debt / EquityFinancial leverage0.01x0.77x
Net DebtTotal debt minus cash-$470M$54.0B
Cash & Equiv.Liquid assets$480M$24.4B
Total DebtShort + long-term debt$10M$78.4B
Interest CoverageEBIT ÷ Interest expense4.71x
Evenly matched — PRVA and UNH each lead in 4 of 8 comparable metrics.

Total Returns (Dividends Reinvested)

Evenly matched — PRVA and UNH each lead in 3 of 6 comparable metrics.

A $10,000 investment in UNH five years ago would be worth $9,746 today (with dividends reinvested), compared to $7,312 for PRVA. Over the past 12 months, PRVA leads with a +5.6% total return vs UNH's -4.7%. The 3-year compound annual growth rate (CAGR) favors PRVA at -7.1% vs UNH's -7.3% — a key indicator of consistent wealth creation.

MetricPRVA logoPRVAPrivia Health Gro…UNH logoUNHUnitedHealth Grou…
YTD ReturnYear-to-date+2.3%+9.8%
1-Year ReturnPast 12 months+5.6%-4.7%
3-Year ReturnCumulative with dividends-19.8%-20.4%
5-Year ReturnCumulative with dividends-26.9%-2.5%
10-Year ReturnCumulative with dividends+4.3%+220.3%
CAGR (3Y)Annualised 3-year return-7.1%-7.3%
Evenly matched — PRVA and UNH each lead in 3 of 6 comparable metrics.

Risk & Volatility

UNH leads this category, winning 2 of 2 comparable metrics.

UNH is the less volatile stock with a 0.59 beta — it tends to amplify market swings less than PRVA's 1.03 beta. A beta below 1.0 means the stock typically moves less than the S&P 500.

MetricPRVA logoPRVAPrivia Health Gro…UNH logoUNHUnitedHealth Grou…
Beta (5Y)Sensitivity to S&P 5001.03x0.59x
52-Week HighHighest price in past year$26.51$404.72
52-Week LowLowest price in past year$18.77$234.60
% of 52W HighCurrent price vs 52-week peak+90.5%+90.7%
RSI (14)Momentum oscillator 0–10059.774.5
Avg Volume (50D)Average daily shares traded872K8.1M
UNH leads this category, winning 2 of 2 comparable metrics.

Analyst Outlook

Insufficient data to determine a leader in this category.

Wall Street rates PRVA as "Buy" and UNH as "Buy". Consensus price targets imply 32.0% upside for PRVA (target: $32) vs 4.9% for UNH (target: $385). UNH is the only dividend payer here at 2.37% yield — a key consideration for income-focused portfolios.

MetricPRVA logoPRVAPrivia Health Gro…UNH logoUNHUnitedHealth Grou…
Analyst RatingConsensus buy/hold/sellBuyBuy
Price TargetConsensus 12-month target$31.67$385.43
# AnalystsCovering analysts2252
Dividend YieldAnnual dividend ÷ price+2.4%
Dividend StreakConsecutive years of raises25
Dividend / ShareAnnual DPS$8.70
Buyback YieldShare repurchases ÷ mkt cap0.0%+1.7%
Insufficient data to determine a leader in this category.
Key Takeaway

UNH leads in 2 of 6 categories — strongest in Valuation Metrics and Risk & Volatility. 3 categories are tied.

Best OverallUnitedHealth Group Incorpor… (UNH)Leads 2 of 6 categories
Loading custom metrics...

PRVA vs UNH: Frequently Asked Questions

10 questions · data-driven answers · updated daily

01

Is PRVA or UNH a better buy right now?

For growth investors, Privia Health Group, Inc.

(PRVA) is the stronger pick with 22. 3% revenue growth year-over-year, versus 11. 8% for UnitedHealth Group Incorporated (UNH). UnitedHealth Group Incorporated (UNH) offers the better valuation at 27. 8x trailing P/E (20. 1x forward), making it the more compelling value choice. Analysts rate Privia Health Group, Inc. (PRVA) a "Buy" — based on 22 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — PRVA or UNH?

On trailing P/E, UnitedHealth Group Incorporated (UNH) is the cheapest at 27.

8x versus Privia Health Group, Inc. at 133. 3x. On forward P/E, UnitedHealth Group Incorporated is actually cheaper at 20. 1x.

03

Which is the better long-term investment — PRVA or UNH?

Over the past 5 years, UnitedHealth Group Incorporated (UNH) delivered a total return of -2.

5%, compared to -26. 9% for Privia Health Group, Inc. (PRVA). Over 10 years, the gap is even starker: UNH returned +220. 3% versus PRVA's +4. 3%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — PRVA or UNH?

By beta (market sensitivity over 5 years), UnitedHealth Group Incorporated (UNH) is the lower-risk stock at 0.

59β versus Privia Health Group, Inc. 's 1. 03β — meaning PRVA is approximately 75% more volatile than UNH relative to the S&P 500. On balance sheet safety, Privia Health Group, Inc. (PRVA) carries a lower debt/equity ratio of 1% versus 77% for UnitedHealth Group Incorporated — giving it more financial flexibility in a downturn.

05

Which is growing faster — PRVA or UNH?

By revenue growth (latest reported year), Privia Health Group, Inc.

(PRVA) is pulling ahead at 22. 3% versus 11. 8% for UnitedHealth Group Incorporated (UNH). On earnings-per-share growth, the picture is similar: Privia Health Group, Inc. grew EPS 63. 6% year-over-year, compared to -14. 7% for UnitedHealth Group Incorporated. Over a 3-year CAGR, PRVA leads at 16. 1% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — PRVA or UNH?

UnitedHealth Group Incorporated (UNH) is the more profitable company, earning 2.

7% net margin versus 1. 1% for Privia Health Group, Inc. — meaning it keeps 2. 7% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: UNH leads at 4. 2% versus 1. 6% for PRVA. At the gross margin level — before operating expenses — UNH leads at 18. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is PRVA or UNH more undervalued right now?

On forward earnings alone, UnitedHealth Group Incorporated (UNH) trades at 20.

1x forward P/E versus 68. 5x for Privia Health Group, Inc. — 48. 4x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for PRVA: 32. 0% to $31. 67.

08

Which pays a better dividend — PRVA or UNH?

In this comparison, UNH (2.

4% yield) pays a dividend. PRVA does not pay a meaningful dividend and should not be held primarily for income.

09

Is PRVA or UNH better for a retirement portfolio?

For long-horizon retirement investors, UnitedHealth Group Incorporated (UNH) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.

59), 2. 4% yield, +220. 3% 10Y return). Both have compounded well over 10 years (UNH: +220. 3%, PRVA: +4. 3%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between PRVA and UNH?

Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: PRVA is a small-cap high-growth stock; UNH is a large-cap quality compounder stock. UNH pays a dividend while PRVA does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.

Stocks Like

PRVA

High-Growth Disruptor

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 8%
Run This Screen
Stocks Like

UNH

Income & Dividend Stock

  • Sector: Healthcare
  • Market Cap > $100B
  • Dividend Yield > 0.9%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform PRVA and UNH on the metrics below

Revenue Growth>
%
(PRVA: 17.4% · UNH: 2.0%)
P/E Ratio<
x
(PRVA: 133.3x · UNH: 27.8x)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.